SCHEMBL3345942

SCHEMBL3345942

Cc1cc(-c2cc(N)ccc2Cl)n[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.54
KDM4E B2RXH2 2/20 0.54
GAA P10253 1/20 0.54
HSD17B10 Q99714 1/20 0.54
PLA2G7 Q13093 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
FGFR1 P11362 1/20 0.43
CDK4 P11802 1/20 0.43
CDK2 P24941 1/20 0.43
KDR P35968 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.41
RAB9A P51151 3/20 0.41
CYP3A4 P08684 2/20 0.40
BRD4 O60885 1/20 0.40
BRDT Q58F21 1/20 0.40
CREBBP Q92793 1/20 0.40
CECR2 Q9BXF3 1/20 0.40
BRD9 Q9H8M2 1/20 0.40
BRD7 Q9NPI1 1/20 0.40
IKBKB O14920 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2614354 0.77 NPC1 (0.64) NPC1KDM4EGAAHSD17B10L3MBTL1
SCHEMBL3345938 0.77 KDM4E (0.44) NPC1KDM4EGAAHSD17B10L3MBTL1
SCHEMBL3346696 0.73 NPC1 (0.53) NPC1KDM4EGAAHSD17B10L3MBTL1
SCHEMBL15908507 0.73 NPC1 (0.67) NPC1KDM4EGAAHSD17B10L3MBTL1
SCHEMBL27942525 0.72 NPC1 (0.49) NPC1KDM4EGAAHSD17B10L3MBTL1
SCHEMBL14456078 0.71 HSP90AA1 (0.50) NPC1KDM4EGAAHSD17B10L3MBTL1
SCHEMBL5271661 0.71 NPC1 (0.60) NPC1KDM4EGAAHSD17B10L3MBTL1
SCHEMBL2807338 0.71 CYP3A4 (0.65) NPC1KDM4EGAAHSD17B10PLA2G7
SCHEMBL10099699 0.70 KDM4E (1.00) NPC1KDM4EGAAHSD17B10L3MBTL1
SCHEMBL9901481 0.70 CCR1 (0.48) NPC1KDM4EHSD17B10PLA2G7SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 NPC1 1906/4885KDM4E 2591/4885GAA 3977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.